 Connection
Susan Apkon to Treatment Outcome
This is a "connection" page, showing publications Susan Apkon has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.036 |
|
|
|
-
McDonald CM, Villa C, Soslow JH, Maharry K, Hogan N, Binks M, Berth KC, Elliott KA, Taylor M, Hor KN, Signorovich J, Henricson EK, Phan HC, Apkon S, Ghosh PS, Tian C, Veerapandiyan A, Ramos-Platt L, Gambetta K, Bernes SM, Varadhachary AS, Iannaccone ST, Laverty CG, Perlman SJ, Bass NE, Mosher K, Butterfield RJ, Mathews KD, Scharf RJ, Smith EC, Emerson JA, Mercuri E, Awadalla MS, Marbán L, Marbán E. Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet. 2026 Aug 22; 408(10556):721-733.
Score: 0.021
-
Fuentes MM, Jimenez N, Apkon SD, Rivara FP. Functional outcomes during inpatient rehabilitation for American Indian and Alaska Native children with traumatic brain injury. J Pediatr Rehabil Med. 2016 May 31; 9(2):133-41.
Score: 0.010
-
Oleszek JL, Chang N, Apkon SD, Wilson PE. Botulinum toxin type a in the treatment of children with congenital muscular torticollis. Am J Phys Med Rehabil. 2005 Oct; 84(10):813-6.
Score: 0.005
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|